Stockreport

Kairos Pharma Prices $6.2 Million Initial Public Offering

Kairos Pharma, Ltd.  (KAPA) 
PDF LOS ANGELES, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”), a clinical stage biopharmaceutical company developing cancer th [Read more]